As of November 2024 Samsung Biologics has a market cap of NZ$79.79 Billion. This makes Samsung Biologics the world's 428th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Nov 17th, 2024 the market cap of Samsung Biologics was reported to be: